Form D · Pharmaceuticals

Neos Therapeutics, Inc.

Grand Prairie, TX · CIK 0001467652

Offering snapshot reported Feb 20, 2015 · SEC filing

Reported sold
$20.6M
Offering amount: $20.6M
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 30, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$10.3M$20.6MJan 7, 2015: $8,000,000.00Jan 7, 2015Feb 20, 2015: $20,624,355.00Feb 20, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$8,000,000 → $20,624,355
  • Reported investors10 → 27

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 20, 2015Amendment$20,624,355$12,624,355vs Jan 7, 201527SEC filing
Jan 7, 2015Initial$8,000,000No comparison10SEC filing
Apr 9, 2014Initial$2,500,000No comparison3SEC filing
Mar 4, 2014Amendment$15,500,170$7,432,930vs Jan 2, 201425SEC filing
Jan 2, 2014Initial$8,067,240No comparison12SEC filing
Jul 16, 2012Initial$18,267,890No comparison41SEC filing
Jun 9, 2011Initial$13,554,505No comparison48SEC filing
Nov 23, 2009Amendment$24,195,000$5,000,000vs Oct 7, 200957SEC filing
Oct 7, 2009Amendment$19,195,000$50,000vs Oct 7, 200956SEC filing
Oct 7, 2009Amendment$19,145,000$4,575,000vs Jul 2, 200955SEC filing
Jul 2, 2009Initial$14,570,000No comparison42SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-231561
Most investors participating in this offering receive warrant with coverage equal to 50% of such investor's amount purchased in this offering.

Source: Form D, filed Feb 20, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Margaret Cabano Executive
John Clark Executive
Chris Clement Director
Christopher Clement Director
Richard Eisenstadt Executive
Dorothy Engelking Executive
Arlen Ewart Executive
Bryant Fong Director
Dorothy Frank Executive
Vipin Garg Director, Executive
Karl Handelsman Director
Alan Heller Director
Bryan Hill Executive
Ellen Hoffing Executive
Ralph Iannelli Director
Margaret Lokash Executive
Steven Lutz Executive
Russ Mc Mahen Executive
Victor Miller Executive
Asif Mughal Executive
Greg Robitaille Director
Edward Schnipper Director
Carolyn Sikes Executive
Stacie Switzer Executive
Mark Tengler Executive
Mark Van Ausdal Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2940 N. Highway 360 Suite 400
Grand Prairie, TX, 75050